OneMedNet Corporation announced the addition of 85 cardiovascular centers and data sources, significantly expanding its Cardiovascular network. This move positions OneMedNet as one of the largest providers for Cardiovascular Real-World data.
This expansion adds 2.7 million annual cardiovascular studies to the company's network. Cardiovascular diseases remain a leading cause of death globally, driving substantial healthcare costs.
The enriched multimodal cardiovascular data network is ideally suited for pharmaceutical and insurance sectors. It offers deeper insights into disease progression, treatment responses, and outcomes, fueling more efficient R&D and accelerating therapeutic development.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.